|Articles|February 1, 2001
- Pharmaceutical Executive-02-01-2001
- Volume 0
- Issue 0
A Right to Dream
Author(s)Wayne Koberstein
Managing expectations is the new alchemy. All manipulators of opinion, from the US president down to the humblest peddler, now seek to minimize what people expect
Advertisement
Articles in this issue
over 25 years ago
The Top Ten Marketing Challenges in Neurologyover 25 years ago
Woman With a Mission: Pfizer's Lisa Egbuonu-DavisAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5